Evaluation of the impact on overall survival curves of patients with metastatic castration-sensitive prostate cancer staged with PET-PSMA and classified according to current prognostic criteria by volume and risk.

Authors: Isadora Martins de Sousa, Luciana de Moura Leite, André Marcondes Braga Ribeiro, Eduardo Nobrega Pereira Lima, José Augusto Rinck

Published: 2025-02-18

DOI: 10.1200/jco.2025.43.5_suppl.36

Source: Full article